6-((3-chlorophenethyl)thio)-9H-purine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 6-((3-chlorophenethyl)thio)-9H-purine
• 英文别名: 6-[2-(3-chlorophenyl)ethylsulfanyl]-7H-purine
• 化学式: C₁₃H₁₁ClN₄S
• 分子量: 290.776
• InChiKey: SCWWIAUMSPJKBG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  79.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  6-mercaptopurine 、 3-氯苯乙基溴 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 4.5h， 以78%的产率得到6-((3-chlorophenethyl)thio)-9H-purine
  参考文献：
  名称：

  EP3854401

  摘要：

  公开号：

文献信息

• CDC7-INHIBITING PURINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS
  申请人：Consejo Superior de Investigaciones Científicas (CSIC)

  公开号：EP3854401A1

  公开（公告）日：2021-07-28

  The present invention relates to the use of a series of purine derivatives having the following general formula: (I) and which are capable of inhibiting CDC7 kinase activity and, therefore, suitable for use in the treatment of neurological diseases such as, inter alia, Alzheimer's disease, amyotrophic lateral sclerosis or frontotemporal dementia, which involve hyperphosphorylation of TDP-43 and the subsequent formation of clusters, induced by CDC7.

  本发明涉及一系列具有以下通式的嘌呤衍生物的用途： (I)，它们能够抑制 CDC7 激酶的活性，因此适用于治疗神经系统疾病，如阿尔茨海默病、肌萎缩侧索硬化症或额颞叶痴呆症等，这些疾病涉及 CDC7 诱导的 TDP-43 过度磷酸化及随后形成的簇。
• Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis
  作者：Elisa Rojas-Prats、Loreto Martinez-Gonzalez、Claudia Gonzalo-Consuegra、Nicole F. Liachko、Concepción Perez、David Ramírez、Brian C. Kraemer、Ángeles Martin-Requero、Daniel I. Perez、Carmen Gil、Eva de Lago、Ana Martinez

  DOI：10.1016/j.ejmech.2020.112968

  日期：2021.1
• CDC7-Inhibiting Purine Derivatives and their use for the Treatment of Neurological Conditions
  申请人：CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

  公开号：US20210346388A1

  公开（公告）日：2021-11-11

  The present invention relates to the use of a series of purine derivatives having the following general formula: (I) and which are capable of inhibiting CDC7 kinase activity and, therefore, suitable for use in the treatment of neurological diseases such as, inter alia, Alzheimer's disease, amyotrophic lateral sclerosis or frontotemporal dementia, which involve hyperphosphorylation of TDP-43 and the subsequent formation of clusters, induced by CDC7.
• EP3854401
  申请人：——

  公开号：——

  公开（公告）日：——